Queen’s University Belfast (QUB) is taking part in a UK-wide trial to investigate whether a drug normally used to treat high blood pressure could also slow down the progression of Alzheimer’s Disease (AD).

A team of scientists from Ulster University, lead by Prof Kathryn Saunders, has successfully proven for the very first time in humans that there is a connection between short-sight (myopia) and the melatonin levels which control the natural body clock.